tiprankstipranks
Advertisement
Advertisement

nDatalyze Joins Semi-Annual Reporting Pilot as RTO and Sports Tech Project Advance

Story Highlights
  • nDatalyze will adopt semi-annual financial reporting to reduce costs and refocus on core AI health solutions.
  • The firm sees its RTO with Prism progressing and is advancing commercialization plans for its Epitome sports tool.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
nDatalyze Joins Semi-Annual Reporting Pilot as RTO and Sports Tech Project Advance

Meet Samuel – Your Personal Investing Prophet

nDatalyze Corp ( (TSE:NDAT) ) has provided an update.

nDatalyze Corp. plans to shift from quarterly to semi-annual financial reporting under the Canadian Securities Administrators’ pilot program, a move it says will cut compliance costs and free management to focus on its core AI-powered mental health technologies. The company will continue to file audited annual results and six-month interim statements while maintaining ongoing material disclosure.

Management also reported progress on a potential reverse takeover with Prism Diversified Ltd., saying pre-RTO financing is advancing and a definitive agreement is expected in the near term. In parallel, nDatalyze has completed a commercialization report for its Epitome sports performance assessment platform, refining target markets, sales channels, pricing strategy and seasonality, and is now weighing commercialization options.

The most recent analyst rating on (TSE:NDAT) stock is a Hold with a C$0.10 price target. To see the full list of analyst forecasts on nDatalyze Corp stock, see the TSE:NDAT Stock Forecast page.

Spark’s Take on NDAT Stock

According to Spark, TipRanks’ AI Analyst, NDAT is a Neutral.

The score is primarily held back by very weak financial performance (collapsed revenue, ongoing losses, and cash burn). Technicals are a key positive with price above major moving averages and positive MACD, while valuation remains pressured by unprofitability. Corporate events add uncertainty due to RTO-related execution and approval risk.

To see Spark’s full report on NDAT stock, click here.

More about nDatalyze Corp

nDatalyze Corp. is a Calgary-based venture issuer that develops technology-driven health and performance solutions, leveraging advanced artificial intelligence and biometric data analysis. The company focuses on mental health applications and related performance assessment tools aimed at specialized markets such as sports development.

Average Trading Volume: 55,938

Technical Sentiment Signal: Buy

Current Market Cap: C$2.89M

For an in-depth examination of NDAT stock, go to TipRanks’ Overview page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1